• Subscriber Content Read Preview

    Health-Care Skirmishes Intensify

    Republican officials urged the Supreme Court to intervene quickly and House Democrats called on Justice Clarence Thomas to sit the case out because of his wife's work for groups opposed to the law.

  • Doctors Hope to Reduce Mastectomies

    Doctors hope that new research recommending less invasive surgery for a certain type of breast cancer could also help them reduce the growing number of women opting for mastectomies.

  • Study Backs Prenatal Spine Fix

    Prenatal surgery for spina bifida, one of the most common disabling birth defects, had significantly more benefit than surgery conducted after birth, and allowed some children to walk who otherwise likely couldn't, according to a major study.

  • Subscriber Content Read Preview

    [sanofi]

    Sanofi, Genzyme Talks Still On

    Sanofi-Aventis reported a 64% drop in fourth-quarter net profit due largely to restructuring costs, and said talks with takeover target Genzyme are continuing, furthering months of suspense surrounding the deal.

  • GOP Seeks to Block Health Law Funds

    House Republicans will use a stopgap spending bill coming to the floor next week as a vehicle to block money for the new health-care law, a top lawmaker said Tuesday.

  • Study: Teen Suicide Rates Diverge

    Teenage girls are about three times as likely as boys to attempt suicide for drug-related reasons, according to an analysis of emergency-room visits.

  • Node Surgery Can Be Skipped for Some

    New research says many breast cancer patients can skip aggressive lymph node surgery without increasing chances for recurrence or death, if their disease shows limited spread.

  • [OB-ML605_workou_A_20110210011019.jpg]

    Taking Time Off to Focus on Fitness

    What's Your Workout: Alison Shaw is trading in her job at Hang Seng Bank to focus on achieving three fitness goals, one of which is to run a 126.6-kilometer ultramarathon.

  • FDA Questions Cancer-Drug Makers

    Federal officials questioned companies that make six cancer drugs about their failure to complete follow-up studies they promised to conduct in exchange for accelerated approval.

  • Subscriber Content Read Preview

    Roche's Avastin Gets a Trial Boost

    Roche said its cancer drug Avastin helped women suffering from ovarian cancer live longer without their disease worsening, raising the odds the medicine will win approval.

  • [CLASSACT]

    Health-Law Program Faces Changes

    The Obama administration is looking at modifying a workers' long-term-care insurance program included in last year's health-care overhaul, responding to criticism that the program is fiscally unsustainable.

  • [RESREPORT]

    Looking Out for Scoliosis

    Research report looks at the latest medical findings, including trying to predict scoliosis by tracking a child's shoe size.

  • [HEALTHCOL]

    In Search of Alcoholism Genes

    Currently, medications for alcoholism work in less than 50% of cases. But genetic research is showing promise in identifying drugs that can help treat alcoholics based on their DNA.

  • [ACHES]

    Making Tattoos Fade Away

    Aches & Claims looks at tattoo-removal products for at-home use.

  • Subscriber Content Read Preview

    Wrist May Be Route To Safer Heart Treatment

    The procedure for cardiac-catheterization is getting a makeover in the U.S., with a new approach that proponents say is safer and more comfortable for patients and potentially cheaper.

  • Subscriber Content Read Preview

    Kindred to Acquire RehabCare

    Kindred Healthcare agreed to acquire RehabCare Group for about $900 million in stock and cash.

  • Help for Hyperventilating

    Researchers are exploring whether patients who are hyperventilating should slow down their breathing to boost the carbon dioxide in their systems.

  • [SOLIDFOOD]

    Obesity Risk for Infants Fed Solids Early

    Infants on formula who are fed solid foods before they are 4 months old have a higher risk of becoming obese by age 3 than those starting later, Harvard researchers said.

  • Subscriber Content Read Preview

    [sanofi0207]

    Sanofi, Genzyme Deal Nears

    Sanofi is taking longer than expected on due diligence for its proposed acquisition of Genzyme, but the companies are confident they can seal a deal this week.

  • Subscriber Content Read Preview

    Aetna's Profit Rises 30%

    Aetna's fourth-quarter earnings rose 30% as the health insurer's medical-claims costs declined, though revenue from premiums fell.

  • Subscriber Content Read Preview

    Opko CEO Adds to Buying

    The doctor who runs Opko Health sharply escalated his purchases of the health-care company's shares last month, and another insider bought shares too.

  • Subscriber Content Read Preview

    After Cutting Prices, 3 IPOs Rise

    BG Medicine rose 15%, Endocyte gained 29%, and MedQuist Holdings ended up 13%. A fourth, Trunkbow International, declined.

  • Health Foes Try Divergent Tactics

    States challenging the massive health-care law enacted last year are employing different tactics in their push for swift Supreme Court review of their legal cases.

  • Justice Dept. Wants Public Release of Tobacco Warning Statements

    The Justice Department plans to ask a federal judge to make public the proposed statements the government wants tobacco companies to publish about the dangers of their products.

  • Subscriber Content Read Preview

    Pfizer, Merck Take Different R&D; Tacks

    The new leaders of the world's two biggest drug companies made divergent choices this week in balancing the billions of dollars they spend on drug research against pressure to deliver better returns for investors.

  • [HAELTHPOL]

    Senate Votes Down Health-Care Repeal

    The Senate voted against repealing the health-care overhaul but approved a measure eliminating a tax requirement that had irked small businesses.

  • House GOP Weighs Medicare Limits

    House Republicans are debating whether to propose new limits on the growth of Medicare and other entitlement programs, weighing a gamble that voters are more concerned about trimming the deficit than holding on to promised benefits.

  • Subscriber Content Read Preview

    Komen Group Cautious on Avastin

    The Susan G. Komen for the Cure organization, a breast-cancer patient-advocacy group, said it isn't promoting the use of the drug Avastin for women who haven't previously taken it.

  • Subscriber Content Read Preview

    Merck Issues Weak View

    Merck swung to a loss on a write-down of the value of an experimental heart drug recently linked to safety concerns, and the drug maker abandoned its prior long-term profit forecast.

Health Blog

What's Your Workout

Research Health

Get in-depth research on Health companies, including complete news and financials, earnings estimates and more.

Dow Jones Industry Tracker - Healthcare

Follow Health News

Answers allows you to tap the knowledge of Community members. Answer a question below or ask a question.

Q: What resources do you use to select a doctor to treat someone in your family?

Top Groups In Health

  • Heath Care Analysis

    Discuss methods for improving the current US healthcare system.

  • Health Journal

    Health Journal columnist Melinda Beck discusses health-care questions with readers, sources and friends.

Partner Center
An Advertising Feature